Welcome to our dedicated page for Afya news (Ticker: AFYA), a resource for investors and traders seeking the latest updates and insights on Afya stock.
Afya Limited (AFYA) delivers essential medical education and digital health solutions across Brazil through its integrated network and technology platforms. This news hub provides investors and healthcare professionals with centralized access to corporate developments, strategic initiatives, and operational updates.
Track official press releases covering financial results, academic partnerships, technology implementations, and regulatory milestones. Our curated collection includes updates on Afya's three core segments: Undergraduate medical programs, Continuing Education certifications, and Digital Services supporting clinical decision-making.
Key updates feature expansion of educational partnerships, digital tool enhancements for healthcare providers, and growth metrics across Afya's learning platforms. Users benefit from chronological organization of material events and strategic announcements without editorial commentary.
Bookmark this page for streamlined monitoring of Afya's progress in merging traditional medical training with innovative digital solutions. Verify publication dates and consult original filings for complete context on all developments.
Afya (Nasdaq: AFYA; B3: A2FY34) has announced that the Secretary of Regulation and Supervision of Higher Education of Brazil's Ministry of Education has approved an increase of 80 medical seats at Centro Universitário de Maceió (UNIMA Alagoas), totaling 220 seats at this institution.
This expansion will incur an additional payment of R$ 1.25 million per seat, adjusted by IPCA from January 2, 2023, until the payment date. This move contributes to Afya's total of 3,583 approved seats, reinforcing its position as a leading medical education provider in Brazil.
Afya has completed the acquisition of Unidompedro and Faculdade Dom Luiz, expanding its presence in Salvador, Brazil. The acquisition brings 300 operational medical school seats, with 125 fully authorized and 175 pending final judicial approval. Afya paid R$ 347.8 million upfront and will pay R$ 312.2 million over ten years, contingent on authorization maintenance. The purchase price could be adjusted based on legal outcomes. Projected Net Revenue for 2024 is R$ 110.5 million, growing to R$ 267 million by 2027. The estimated EV/EBITDA at maturity is 4.2x post synergies.
Afya (Nasdaq: AFYA; B3: A2FY34), a leading medical education group in Brazil, announced the resignation of Mrs. Shobhna Mohn from its Board of Directors, effective June 30, 2024. Mohn's departure is unrelated to Afya’s operations or practices. During her tenure, she contributed significantly to Afya's growth, supporting its journey to becoming a top medical education and practice solutions provider in Brazil. Afya highlighted her strategic insights and leadership as pivotal to its success. The company has no immediate plans to fill her position. The board remains committed to strong governance with diverse skills and experience.
Afya (Nasdaq: AFYA; B3: A2FY34), a leading medical education and practice solutions provider in Brazil, announced the successful passage of a key resolution at its Annual General Meeting on June 5, 2024. Shareholders approved and ratified the company's financial statements and the auditor’s report for the fiscal year ending December 31, 2023.
Afya has announced its Annual General Meeting (AGM) scheduled for June 5, 2024, at 10:00 a.m. BRT. The meeting will take place at their Nova Lima office and virtually through a provided link. The main agenda item is the approval and ratification of the company's financial statements and the auditor's report for the fiscal year ending December 31, 2023. The record date for shareholders eligible to attend is May 10, 2024. The company encourages shareholders to participate and vote, either in person or via proxy. The company's financial statements are available on their investor relations website.
Afya reported solid financial results for the first quarter of 2024, with a 13.3% increase in net revenue to R$804.2 million and a 20.5% growth in adjusted EBITDA to R$397.9 million, leading to an adjusted EBITDA margin expansion of 300 bps. The company also saw significant increases in net income and adjusted net income. Afya's ecosystem reached 334,368 users, reflecting its strong presence in the medical education and practice solutions market in Brazil. The company reaffirmed its guidance for 2024, aiming for continued growth and acquisitions to enhance its offerings.
Afya has announced the acquisition of Unidompedro and Faculdade Dom Luiz, adding 300 medical school seats in Brazil. The purchase price is R$660.0 million, with payment split between cash and installments. The transaction is subject to regulatory approval.
FAQ
What is the current stock price of Afya (AFYA)?
What is the market cap of Afya (AFYA)?
